LMR Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.31M | Sell |
7,887
-10,000
| -56% | -$3.29M | 0.01% | 828 |
|
|
2025
Q4 | $6.27M | Hold |
17,887
| – | – | 0.01% | 514 |
|
|
2025
Q3 | $5.78M | Buy |
17,887
+10,000
| +127% | +$3.11M | 0.03% | 472 |
|
|
2025
Q2 | $3.07M | Hold |
7,887
| – | – | 0.02% | 567 |
|
|
2025
Q1 | $3.43M | Hold |
7,887
| – | – | 0.03% | 523 |
|
|
2024
Q4 | $2.91M | Sell |
7,887
-55
| -0.7% | -$23K | 0.02% | 508 |
|
|
2024
Q3 | $4.13M | Sell |
7,942
-9,483
| -54% | -$5.07M | 0.03% | 413 |
|
|
2024
Q2 | $9.44M | Buy |
17,425
+13,404
| +333% | +$7.09M | 0.08% | 220 |
|
|
2024
Q1 | $2.09M | Buy |
4,021
+1,056
| +36% | +$525K | 0.02% | 542 |
|
|
2023
Q4 | $1.4M | Sell |
2,965
-4,011
| -57% | -$1.85M | 0.02% | 526 |
|
|
2023
Q3 | $3.04M | Sell |
6,976
-911
| -12% | -$413K | 0.03% | 344 |
|
|
2023
Q2 | $3.5M | Buy |
7,887
+1,599
| +25% | +$738K | 0.04% | 290 |
|
|
2023
Q1 | $2.89M | Buy |
6,288
+1,494
| +31% | +$711K | 0.04% | 357 |
|
|
2022
Q4 | $2.46M | Sell |
4,794
-3,093
| -39% | -$1.57M | 0.04% | 465 |
|
|
2022
Q3 | $3.58M | Hold |
7,887
| – | – | 0.07% | 349 |
|
|
2022
Q2 | $3.81M | Buy |
7,887
+875
| +12% | +$433K | 0.06% | 340 |
|
|
2022
Q1 | $3.44M | Buy |
+7,012
| New | +$3.21M | 0.04% | 403 |
|
|
2021
Q3 | – | Sell |
-949
| Closed | -$362K | – | 1053 |
|
|
2021
Q2 | $362K | Buy |
+949
| New | +$363K | 0.01% | 726 |
|
|
2020
Q3 | – | Sell |
-8,073
| Closed | -$2.12M | – | 508 |
|
|
2020
Q2 | $2.12M | Buy |
+8,073
| New | +$2.15M | 0.05% | 243 |
|
|
2019
Q4 | – | Sell |
-2,114
| Closed | -$508K | – | 438 |
|
|
2019
Q3 | $508K | Sell |
2,114
-1,265
| -37% | -$347K | 0.03% | 267 |
|
|
2019
Q2 | $954K | Buy |
+3,379
| New | +$923K | 0.03% | 240 |
|
|
2019
Q1 | – | Sell |
-10,040
| Closed | -$2.64M | – | 395 |
|
|
2018
Q4 | $2.64M | Buy |
+10,040
| New | +$2.76M | 0.13% | 87 |
|
|
2018
Q3 | – | Sell |
-3,055
| Closed | -$727K | – | 402 |
|
|
2018
Q2 | $727K | Sell |
3,055
-6,167
| -67% | -$1.43M | 0.04% | 215 |
|
|
2018
Q1 | $2.08M | Hold |
9,222
| – | – | 0.21% | 88 |
|
|
2017
Q4 | $2.08M | Buy |
9,222
+4,365
| +90% | +$930K | 0.21% | 88 |
|
|
2017
Q3 | $922K | Sell |
4,857
-9,860
| -67% | -$1.88M | 0.1% | 107 |
|
|
2017
Q2 | $2.77M | Buy |
+14,717
| New | +$2.64M | 0.17% | 120 |
|
|
2017
Q1 | – | Sell |
-1,686
| Closed | -$242K | – | 390 |
|
|
2016
Q4 | $242K | Buy |
+1,686
| New | +$226K | 0.04% | 301 |
|
|
2016
Q2 | – | Sell |
-9,068
| Closed | -$1.26K | – | 509 |
|
|
2016
Q1 | $1.26K | Buy |
9,068
+7,523
| +487% | +$1.01M | 0.14% | 142 |
|
|
2015
Q4 | $216K | Sell |
1,545
-12,002
| -89% | -$1.65M | 0.07% | 199 |
|
|
2015
Q3 | $1.9M | Sell |
13,547
-15,331
| -53% | -$2.3M | 0.21% | 110 |
|
|
2015
Q2 | $4.74M | Buy |
28,878
+4,257
| +17% | +$680K | 0.58% | 25 |
|
|
2015
Q1 | $3.8M | Sell |
24,621
-3,080
| -11% | -$439K | 0.53% | 57 |
|
|
2014
Q4 | $3.48M | Buy |
+27,701
| New | +$3.42M | 0.45% | 38 |
|
|
2014
Q3 | – | Sell |
-15,817
| Closed | -$1.7M | – | 370 |
|
|
2014
Q2 | $1.7M | Buy |
+15,817
| New | +$1.63M | 0.14% | 192 |
|
Other funds holding ELV
VCM
VPM
LMR Partners's ELV Position: Q1 2026 in Review
LMR Partners reduced its Elevance Health (ELV) stake by 56% in Q1 2026, selling an estimated $3.29M and leaving 7,887 shares worth $2.31M. The position accounts for 0.01% of the portfolio, ranked #828.
LMR Partners first reported a position in ELV in Q2 2014 and has held it in 35 quarters since. The position peaked at $9.44M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- LMR Partners held 7,887 shares of Elevance Health worth $2.31M as of Q1 2026.
- LMR Partners sold 10,000 Elevance Health shares in Q1 2026, an estimated $3.29M.
- Elevance Health made up 0.01% of LMR Partners's portfolio in Q1 2026, its #828 holding.
- LMR Partners first reported a position in Elevance Health in Q2 2014 and has held it in 35 quarters since.
- LMR Partners's Elevance Health position peaked at $9.44M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.